ZBIO vs LQDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LQDA Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Liquidia Corporation Common Stock (LQDA) driven by superior Valuation, Growth & Margin, Momentum & Technical while ZBIO counters with relative strength in Options & Structure. Fundamentally, ZBIO trades at N/M Forward P/E with -2747.5% operating margin (-100.0% YoY revenue) versus LQDA at 16.4x Forward P/E and 47.1% operating margin (+314.6% YoY). In options structure, ZBIO sits in CONSOLIDATION (13th %ile IV; Dealer Gamma Walls on Pro) against LQDA sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ZBIO Revenue | LQDA Revenue | ZBIO Op. Margin | LQDA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -580.1% | LQDA |
| FY2020 | N/A | $0M | N/A | -7989.0% | LQDA |
| FY2021 | N/A | $10M | N/A | -263.0% | LQDA |
| FY2022 | N/A | $20M | N/A | -243.3% | LQDA |
| FY2023 | $50M | $20M | -74.3% | -419.6% | ZBIO |
| FY2024 | $10M | $10M | -3277.8% | -866.6% | LQDA |
| FY2025 | $10M | $160M | -3830.6% | -32.5% | LQDA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZBIO | LQDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9B | $5.2B | Larger Scale | LQDA |
| Trailing P/E Ratio Valuation | N/M | 13.8x | Lower Multiple | LQDA |
| Forward P/E Ratio Valuation | N/M | 16.4x | Lower Multiple | LQDA |
| Revenue Growth (YoY) Growth | -100.0% | +314.6% | Higher Growth | LQDA |
| Operating Margin (TTM) Profitability | -2747.5% | 47.1% | Higher Margin | LQDA |
| Net Profit Margin Profitability | 0.0% | -15.2% | Higher Margin | ZBIO |
| Return on Equity (ROE) Capital Efficiency | -265.1% | 131.8% | Higher ROE | LQDA |
| 52-Week Range Position Momentum | 46% ($14โ$45) | 48% ($22โ$94) | Stronger Trend | LQDA |
| Beta / 30D Volatility Risk Regime | 1.16ฮฒ ยท 59% Vol | 0.99ฮฒ ยท 77% Vol | Lower Realized Risk | ZBIO |
| Unified Institutional Score Composite Signal | 49.4 / 100 (HOLD) | 25.6 / 100 (SELL) | Higher Composite | ZBIO |